EWA
VRCA icon

EverSource Wealth Advisors’s Verrica Pharmaceuticals VRCA Stock Holding History

EverSource Wealth Advisors’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5
Closed -$26 – 4492
2025
Q2 		$26 Sell
5
-8
-62% -$43 ﹤0.01% 4216
2025
Q1 		$56 Buy
+13
New +$84 ﹤0.01% 3889
2022
Q2 		– Sell
-43
Closed -$3K – 1897
2022
Q1 		$3K Buy
+43
New +$3.54K ﹤0.01% 1464

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

EverSource Wealth Advisors's VRCA Position: Q3 2025 in Review

EverSource Wealth Advisors sold out of Verrica Pharmaceuticals (VRCA) in Q3 2025, closing a stake of 5 shares — an estimated $26 sold.

EverSource Wealth Advisors first reported a position in VRCA in Q1 2022 and held it in 3 quarters. The position peaked at $3K in Q1 2022. 34 funds tracked by Wall St. Rank hold VRCA as of Q3 2025.

  • EverSource Wealth Advisors reported no remaining Verrica Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 5 Verrica Pharmaceuticals shares in Q3 2025, an estimated $26.
  • EverSource Wealth Advisors first reported a position in Verrica Pharmaceuticals in Q1 2022 and held it in 3 quarters.
  • EverSource Wealth Advisors's Verrica Pharmaceuticals position peaked at $3K in Q1 2022.
  • 34 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2025.

Based on EverSource Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.